Medical Supply Chains During the Pandemic: Lessons Learned and Best Practices
June 23 at 12:00 pm PDT / 3:00 pm EDT
The COVID-19 pandemic tested US and global supply chains by requiring the production and distribution of hundreds of millions of units of key medical products at unprecedented speed. In contrast to earlier crises, when local shortages could be solved by shifting products from unaffected markets, the pandemic caused a worldwide spike in demand that removed the slack from supply chains, creating new logistical challenges.
Ultimately, the supply chain proved resilient enough to deliver essential supplies on an unprecedented scale. However, the crisis shed light on vulnerabilities in national preparedness and the need for greater coordination and collaboration.
As we emerge from this crisis, the supply chain is applying lessons learned and best practices to prepare for the next one. How can the public and private sector work together to make sure the United States is ready for the next public health crisis?
Moderator
Nicholas Florko
Washington Correspondent, STAT
Speakers
Chester "Chip" Davis, Jr.
President and CEO, Healthcare Distribution Alliance
Nicolette Louissaint
Executive Director, Healthcare Ready
Bill Peacock
Chief of Operations, Cleveland Clinic
Matthew Wilson
Senior Partner, McKinsey & Company, Inc.
Materials
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
COVID-19 Vaccines: Global Coordination and Equitable Distribution